Liquid Biopsy

Oncological diseases represent one of the most serious threats to public health both due to their prevalence and severe impact on patients´ quality of life as well as the immense financial expenses they impose on on government health insurance systems.  Timely and accurate diagnosis is the key to effective treatment and improving patient prognosis. In this context, liquid biopsy is becoming a breakthrough method that offers a range of advantages over traditional tissue biopsy. Recognize it in time with AveGene.

Non-invasive and gentler approach 
Liquid biopsy involves analyzing a blood sample (or other bodily fluids), eliminating the need for invasive tissue sampling. This is crucial, especially for patients where a traditional biopsy cannot be performed due to the location of the tumor or the patient's health condition. The method is quick, less painful, and minimizes the risks associated with surgical procedures.

Early detection of tumors and disease monitoring
Liquid biopsy allows for the detection of circulating tumor DNA (ctDNA), exosomes, and other biomarkers even in the early stages of cancer, when the disease is often asymptomatic. Thanks to this capability, tumor diseases can be detected earlier than with traditional imaging methods, which significantly increases the chances of successful treatment.

Moreover, liquid biopsy can be regularly repeated, allowing for the monitoring of disease progression, therapy effectiveness, and potential treatment resistance.

More precise and comprehensive information
Tumors are genetically heterogeneous, which means that traditional biopsies often capture only a portion of the genetic changes in the tumor. Liquid biopsy provides a more comprehensive picture because it analyzes free tumor DNA released into the bloodstream from various parts of the tumor and metastases. This allows doctors to better identify genetic mutations that are key to choosing personalized therapy.

Reduction of diagnostic time
The process of processing a liquid biopsy is less time-consuming. Compared to tissue biopsies, which require surgical intervention and lengthy laboratory processing, the result of a liquid biopsy can be available within a few days. This speed is crucial for initiating treatment in patients where time is of the essence.

Cost-effectiveness
Although the implementation of new technology requires initial investments, liquid biopsy can reduce long-term costs associated with diagnostics. Lower demands for invasive procedures, shorter hospitalizations, and more precise treatment choices contribute to a more efficient use of healthcare system resources.

Liquid biopsy represents a modern, gentle, and precise method for diagnosing oncological diseases. Its ability to detect cancer early, monitor treatment efficacy, and provide comprehensive genetic information can significantly improve treatment outcomes and patients' quality of life. The implementation of this technology into routine clinical practice is a step towards more modern and efficient oncological care.